HANDOK Inc. (KRX:002390)

Market Cap	169.43B
Revenue (ttm)	498.45B
Net Income (ttm)	-58.00B
Shares Out	13.76M
EPS (ttm)	-4,217.28
PE Ratio	n/a
Forward PE	n/a
Dividend	200.00 (1.66%)
Ex-Dividend Date	Feb 27, 2025

Volume	24,551
Average Volume	33,160
Open	12,120
Previous Close	12,030
Day's Range	12,000 - 12,400
52-Week Range	10,500 - 18,170
Beta	0.49
RSI	65.43
Earnings Date	Aug 12, 2025

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet brand; foo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 950
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.